One thing we could say about the analysts on Seer, Inc. (NASDAQ:SEER) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization ...
One thing we could say about the analysts on Seer, Inc. (NASDAQ:SEER) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization ...
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature ...
Good day and thank you for standing by. Welcome to the Seer Fourth Quarter and Full-Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's ...
Omid C. Farokhzad, Founder, CEO & Chair of the Board, stated Q2 2025 was a pivotal quarter with "discipline, advance key commercial and product milestones and accelerate the validation and impact of ...
Seer and Korea University launch a study to identify blood-based cancer biomarkers using advanced mass spectrometry and AI analytics. Seer, Inc. and Korea University have launched a groundbreaking ...
Seer, Inc. (Nasdaq: SEER), announced the launch of its new Proteograph ® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument—its most advanced solution yet for scalable, ...
Rhenn is a Manila-based content writer with a love for all things geek and pop culture, and science and technology. He graduated BA Journalism degree as a Cum Laude, and has since then pursued making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback